エル・ティー・エスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/11/01 | 3,250 | 3,285 | 3,205 | 3,240 | +15 | +0.5% | 15,900 |
2021/10/29 | 3,200 | 3,225 | 3,180 | 3,225 | +10 | +0.3% | 7,900 |
2021/10/28 | 3,205 | 3,230 | 3,175 | 3,215 | +15 | +0.5% | 12,200 |
2021/10/27 | 3,225 | 3,230 | 3,165 | 3,200 | -30 | -0.9% | 8,000 |
2021/10/26 | 3,155 | 3,260 | 3,135 | 3,230 | +125 | +4% | 19,900 |
2021/10/25 | 3,180 | 3,180 | 3,090 | 3,105 | -80 | -2.5% | 17,400 |
2021/10/22 | 3,195 | 3,240 | 3,165 | 3,185 | +25 | +0.8% | 12,000 |
2021/10/21 | 3,260 | 3,260 | 3,160 | 3,160 | -115 | -3.5% | 16,300 |
2021/10/20 | 3,340 | 3,340 | 3,255 | 3,275 | -15 | -0.5% | 13,200 |
2021/10/19 | 3,285 | 3,340 | 3,285 | 3,290 | +5 | +0.2% | 8,000 |
2021/10/18 | 3,265 | 3,320 | 3,245 | 3,285 | +30 | +0.9% | 10,900 |
2021/10/15 | 3,210 | 3,270 | 3,190 | 3,255 | +90 | +2.8% | 13,300 |
2021/10/14 | 3,205 | 3,240 | 3,150 | 3,165 | +10 | +0.3% | 18,700 |
2021/10/13 | 3,305 | 3,305 | 3,155 | 3,155 | -145 | -4.4% | 27,800 |
2021/10/12 | 3,400 | 3,400 | 3,300 | 3,300 | -100 | -2.9% | 21,700 |
2021/10/11 | 3,325 | 3,420 | 3,230 | 3,400 | +130 | +4% | 34,000 |
2021/10/08 | 3,165 | 3,295 | 3,165 | 3,270 | +175 | +5.7% | 34,600 |
2021/10/07 | 3,130 | 3,170 | 3,055 | 3,095 | ±0 | ±0% | 32,400 |
2021/10/06 | 3,190 | 3,255 | 3,075 | 3,095 | -55 | -1.7% | 28,900 |
2021/10/05 | 3,170 | 3,240 | 3,050 | 3,150 | -100 | -3.1% | 42,600 |
2021/10/04 | 3,385 | 3,420 | 3,215 | 3,250 | -120 | -3.6% | 34,400 |
2021/10/01 | 3,400 | 3,405 | 3,300 | 3,370 | -40 | -1.2% | 33,700 |
2021/09/30 | 3,470 | 3,485 | 3,405 | 3,410 | -95 | -2.7% | 17,400 |
2021/09/29 | 3,435 | 3,525 | 3,420 | 3,505 | -20 | -0.6% | 37,200 |
2021/09/28 | 3,545 | 3,545 | 3,445 | 3,525 | -20 | -0.6% | 15,500 |
2021/09/27 | 3,600 | 3,640 | 3,545 | 3,545 | -55 | -1.5% | 14,400 |
2021/09/24 | 3,540 | 3,635 | 3,530 | 3,600 | +200 | +5.9% | 24,100 |
2021/09/22 | 3,510 | 3,530 | 3,400 | 3,400 | -125 | -3.5% | 25,800 |
2021/09/21 | 3,500 | 3,575 | 3,480 | 3,525 | -145 | -4% | 25,400 |
2021/09/17 | 3,665 | 3,710 | 3,595 | 3,670 | +20 | +0.5% | 17,100 |
2021/09/16 | 3,765 | 3,765 | 3,530 | 3,650 | -80 | -2.1% | 51,400 |
2021/09/15 | 3,790 | 3,865 | 3,725 | 3,730 | -65 | -1.7% | 28,400 |
2021/09/14 | 3,750 | 3,795 | 3,725 | 3,795 | +80 | +2.2% | 27,300 |
2021/09/13 | 3,675 | 3,715 | 3,625 | 3,715 | ±0 | ±0% | 23,900 |
2021/09/10 | 3,635 | 3,715 | 3,635 | 3,715 | +70 | +1.9% | 26,400 |
2021/09/09 | 3,650 | 3,695 | 3,640 | 3,645 | +5 | +0.1% | 13,200 |
2021/09/08 | 3,555 | 3,660 | 3,555 | 3,640 | +90 | +2.5% | 26,900 |
2021/09/07 | 3,650 | 3,680 | 3,535 | 3,550 | -75 | -2.1% | 31,600 |
2021/09/06 | 3,585 | 3,630 | 3,540 | 3,625 | +105 | +3% | 23,000 |
2021/09/03 | 3,450 | 3,565 | 3,445 | 3,520 | +95 | +2.8% | 34,900 |
2021/09/02 | 3,505 | 3,505 | 3,410 | 3,425 | -80 | -2.3% | 20,700 |
2021/09/01 | 3,500 | 3,530 | 3,455 | 3,505 | -10 | -0.3% | 19,200 |
2021/08/31 | 3,450 | 3,520 | 3,450 | 3,515 | +65 | +1.9% | 15,600 |
2021/08/30 | 3,425 | 3,495 | 3,425 | 3,450 | +80 | +2.4% | 19,000 |
2021/08/27 | 3,425 | 3,430 | 3,350 | 3,370 | -55 | -1.6% | 22,500 |
2021/08/26 | 3,400 | 3,445 | 3,360 | 3,425 | +40 | +1.2% | 24,600 |
2021/08/25 | 3,440 | 3,450 | 3,340 | 3,385 | -20 | -0.6% | 22,700 |
2021/08/24 | 3,355 | 3,485 | 3,355 | 3,405 | +70 | +2.1% | 26,000 |
2021/08/23 | 3,260 | 3,375 | 3,260 | 3,335 | +75 | +2.3% | 24,800 |
2021/08/20 | 3,305 | 3,410 | 3,245 | 3,260 | -10 | -0.3% | 21,600 |
751~
800
件表示中 / 1694件
類似銘柄と比較する
現在ご覧いただいている「LTS」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
LTS | 230,600円 | +34.8% | +52.7% | 1.30% | 10.71倍 | 2.74倍 |
|
ビジネスプロセス可視化・改善・実行支援など展開、ITビジネスマッチング「アサインナビ」も |
メドピア | 49,100円 | -17.1% | -35.1% | 0.92% | 21.33倍 | 1.13倍 |
|
医師向け情報サイト運営、製薬会社の広告料が収益源。法人向け医療相談や特定保健指導も展開 |
FCE | 97,200円 | +14.9% | +29.6% | 1.44% | 16.86倍 | 3.15倍 |
|
業務改善用RPAソフトでDX支援。クラウドサービスでeラーニング展開。配当性向25%目安 |
MDNT | 4,000円 | +21.1% | - | 0.00% | - | 2.04倍 |
|
東大医科研発。がん免疫細胞療法の細胞加工が核。医薬品開発、医薬品受託製造(CDMO)も |
ZETA | 40,900円 | -54.0% | - | 1.71% | 282.07倍 | 7.62倍 |
|
ZETAを子会社化しビッグデータ活用の推奨商品表示(CX改善)が柱に。ネット広告は撤退 |
市場注目の銘柄
チャート関連のコラム